Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$106.89
$113.77
$89.67
$121.64
$185.47B0.745.69 million shs3.11 million shs
Dover Co. stock logo
DOV
Dover
$179.07
+4.5%
$171.37
$127.25
$181.49
$24.60B1.27966,180 shs2.23 million shs
Kimberly-Clark Co. stock logo
KMB
Kimberly-Clark
$136.43
-1.0%
$125.53
$116.32
$147.09
$45.96B0.42.23 million shs3.02 million shs
The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.00%+1.54%-4.14%-4.57%-1.71%
Dover Co. stock logo
DOV
Dover
+4.46%+6.20%+2.48%+19.43%+27.17%
Kimberly-Clark Co. stock logo
KMB
Kimberly-Clark
-0.98%+8.61%+8.20%+12.59%-5.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Abbott Laboratories stock logo
ABT
Abbott Laboratories
4.9927 of 5 stars
3.35.04.24.52.52.52.5
Dover Co. stock logo
DOV
Dover
4.5113 of 5 stars
2.35.04.22.11.12.51.9
Kimberly-Clark Co. stock logo
KMB
Kimberly-Clark
4.6068 of 5 stars
2.04.04.22.53.83.31.3

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Abbott Laboratories stock logo
ABT
Abbott Laboratories
2.67
Moderate Buy$121.5013.67% Upside
Dover Co. stock logo
DOV
Dover
2.67
Moderate Buy$175.13-2.20% Downside
Kimberly-Clark Co. stock logo
KMB
Kimberly-Clark
2.00
Hold$134.85-1.16% Downside

Current Analyst Ratings

Latest KMB, DOV, and ABT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/25/2024
Kimberly-Clark Co. stock logo
KMB
Kimberly-Clark
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$132.00 ➝ $136.00
4/24/2024
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy$124.00
4/24/2024
Kimberly-Clark Co. stock logo
KMB
Kimberly-Clark
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetSell ➝ Sell$111.00 ➝ $125.00
4/24/2024
Kimberly-Clark Co. stock logo
KMB
Kimberly-Clark
HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$146.00 ➝ $150.00
4/24/2024
Kimberly-Clark Co. stock logo
KMB
Kimberly-Clark
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetSector Perform ➝ Sector Perform$123.00 ➝ $126.00
4/24/2024
Kimberly-Clark Co. stock logo
KMB
Kimberly-Clark
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetUnderperform ➝ Underperform$110.00 ➝ $115.00
4/24/2024
Kimberly-Clark Co. stock logo
KMB
Kimberly-Clark
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$135.00 ➝ $138.00
4/24/2024
Kimberly-Clark Co. stock logo
KMB
Kimberly-Clark
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$135.00 ➝ $152.00
4/24/2024
Kimberly-Clark Co. stock logo
KMB
Kimberly-Clark
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$131.00 ➝ $136.00
4/24/2024
Kimberly-Clark Co. stock logo
KMB
Kimberly-Clark
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetUnderweight ➝ Underweight$115.00 ➝ $123.00
4/22/2024
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$141.00 ➝ $140.00
(Data available from 4/26/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$40.11B4.62$6.32 per share16.91$22.36 per share4.78
Dover Co. stock logo
DOV
Dover
$8.44B2.92$11.55 per share15.51$36.50 per share4.91
Kimberly-Clark Co. stock logo
KMB
Kimberly-Clark
$20.43B2.25$8.84 per share15.43$3.51 per share38.87

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$5.72B$3.2133.3020.882.5913.96%20.32%10.59%7/18/2024 (Estimated)
Dover Co. stock logo
DOV
Dover
$1.06B$7.5223.8118.141.7912.52%25.95%11.29%N/A
Kimberly-Clark Co. stock logo
KMB
Kimberly-Clark
$1.76B$5.4425.0818.824.059.05%250.28%13.58%7/23/2024 (Estimated)

Latest KMB, DOV, and ABT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/23/2024Q1 2024
Kimberly-Clark Co. stock logo
KMB
Kimberly-Clark
$1.61$2.01+$0.40$2.11$5.08 billion$5.15 billion      
4/17/2024Q1 24
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$0.96$0.98+$0.02$1.26$9.88 billion$9.96 billion    
2/1/2024Q4 2023
Dover Co. stock logo
DOV
Dover
$2.44$2.45+$0.01$2.79$2.16 billion$2.11 billion    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$2.202.06%+12.31%68.54%53 Years
Dover Co. stock logo
DOV
Dover
$2.041.14%+1.01%27.13%69 Years
Kimberly-Clark Co. stock logo
KMB
Kimberly-Clark
$4.883.58%+3.32%89.71%53 Years

Latest KMB, DOV, and ABT Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/16/2024
Abbott Laboratories stock logo
ABT
Abbott Laboratories
quarterly$0.551.9%4/12/20244/15/20245/15/2024
2/8/2024
Dover Co. stock logo
DOV
Dover
quarterly$0.511.27%2/28/20242/29/20243/15/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.35
1.64
1.16
Dover Co. stock logo
DOV
Dover
0.59
1.40
0.90
Kimberly-Clark Co. stock logo
KMB
Kimberly-Clark
6.05
0.81
0.54

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Abbott Laboratories stock logo
ABT
Abbott Laboratories
75.18%
Dover Co. stock logo
DOV
Dover
84.46%
Kimberly-Clark Co. stock logo
KMB
Kimberly-Clark
76.29%

Insider Ownership

CompanyInsider Ownership
Abbott Laboratories stock logo
ABT
Abbott Laboratories
1.10%
Dover Co. stock logo
DOV
Dover
1.30%
Kimberly-Clark Co. stock logo
KMB
Kimberly-Clark
0.62%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Abbott Laboratories stock logo
ABT
Abbott Laboratories
114,0001.74 billion1.72 billionOptionable
Dover Co. stock logo
DOV
Dover
25,000137.38 million135.59 millionOptionable
Kimberly-Clark Co. stock logo
KMB
Kimberly-Clark
41,000336.91 million334.83 millionOptionable

KMB, DOV, and ABT Headlines

SourceHeadline
Kimberly-Clark (NYSE:KMB) Price Target Raised to $136.00Kimberly-Clark (NYSE:KMB) Price Target Raised to $136.00
marketbeat.com - April 25 at 3:31 PM
Options Exercise Activity Initiated By Paula Ramos At Kimberly-ClarkOptions Exercise Activity Initiated By Paula Ramos At Kimberly-Clark
benzinga.com - April 25 at 2:35 PM
ADRNY or KMB: Which Is the Better Value Stock Right Now?ADRNY or KMB: Which Is the Better Value Stock Right Now?
zacks.com - April 25 at 12:45 PM
Kimberly-Clark Corporation (KMB) Q1 2024 Earnings Call TranscriptKimberly-Clark Corporation (KMB) Q1 2024 Earnings Call Transcript
seekingalpha.com - April 25 at 9:34 AM
Is Kimberly-Clark Stock Fairly Valued At $135 After A Solid Q1?Is Kimberly-Clark Stock Fairly Valued At $135 After A Solid Q1?
forbes.com - April 25 at 9:34 AM
Liv by Kotex® Wants Moms to Laugh - and Pee a Little - this Mothers DayLiv by Kotex® Wants Moms to Laugh - and Pee a Little - this Mother's Day
finance.yahoo.com - April 25 at 9:34 AM
Kimberly-Clark Corporation Just Beat Earnings Expectations: Heres What Analysts Think Will Happen NextKimberly-Clark Corporation Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
finance.yahoo.com - April 25 at 9:34 AM
Kimberly-Clark Co. (NYSE:KMB) Insider Paula Ramos Sells 10,178 SharesKimberly-Clark Co. (NYSE:KMB) Insider Paula Ramos Sells 10,178 Shares
insidertrades.com - April 25 at 7:02 AM
Kimberly-Clark (NYSE:KMB) Given New $125.00 Price Target at CitigroupKimberly-Clark (NYSE:KMB) Given New $125.00 Price Target at Citigroup
americanbankingnews.com - April 25 at 6:16 AM
Kimberly-Clark (NYSE:KMB) Price Target Increased to $126.00 by Analysts at Royal Bank of CanadaKimberly-Clark (NYSE:KMB) Price Target Increased to $126.00 by Analysts at Royal Bank of Canada
americanbankingnews.com - April 25 at 6:16 AM
Kimberly-Clark (NYSE:KMB) Given New $150.00 Price Target at HSBCKimberly-Clark (NYSE:KMB) Given New $150.00 Price Target at HSBC
americanbankingnews.com - April 25 at 6:16 AM
Kimberly-Clark (NYSE:KMB) Shares Gap Up  After Strong EarningsKimberly-Clark (NYSE:KMB) Shares Gap Up After Strong Earnings
americanbankingnews.com - April 25 at 5:44 AM
Kimberly-Clark Corp Chief Human Resources Officer Sells Company SharesKimberly-Clark Corp Chief Human Resources Officer Sells Company Shares
finance.yahoo.com - April 25 at 4:33 AM
Kimberly-Clark Co. (NYSE:KMB) Shares Sold by Members Capital Advisors Inc.Kimberly-Clark Co. (NYSE:KMB) Shares Sold by Members Capital Advisors Inc.
marketbeat.com - April 24 at 10:52 PM
Underperform Rating Maintained for Kimberly Clark Amid Cost Concerns and Mixed Financial OutlookUnderperform Rating Maintained for Kimberly Clark Amid Cost Concerns and Mixed Financial Outlook
markets.businessinsider.com - April 24 at 6:32 PM
A Closer Look at 10 Analyst Recommendations For Kimberly-ClarkA Closer Look at 10 Analyst Recommendations For Kimberly-Clark
markets.businessinsider.com - April 24 at 6:32 PM
Kimberly-Clark Corporation (NYSE:KMB) Q1 2024 Earnings Call TranscriptKimberly-Clark Corporation (NYSE:KMB) Q1 2024 Earnings Call Transcript
finance.yahoo.com - April 24 at 1:28 PM
Kimberly-Clark (NYSE:KMB) Posts Quarterly  Earnings Results, Beats Estimates By $0.40 EPSKimberly-Clark (NYSE:KMB) Posts Quarterly Earnings Results, Beats Estimates By $0.40 EPS
marketbeat.com - April 24 at 12:10 PM
Kimberly-Clark +5% After Q1 Results - Heres WhyKimberly-Clark +5% After Q1 Results - Here's Why
msn.com - April 24 at 3:00 AM
Kimberly-Clark Corp. (KMB) Quarterly Report: What Does It Reveal About Their Sector PerformanceKimberly-Clark Corp. (KMB) Quarterly Report: What Does It Reveal About Their Sector Performance
americanbankingnews.com - April 24 at 2:05 AM
Schnieders Capital Management LLC Cuts Position in Kimberly-Clark Co. (NYSE:KMB)Schnieders Capital Management LLC Cuts Position in Kimberly-Clark Co. (NYSE:KMB)
marketbeat.com - April 23 at 11:25 PM
Buy Rating Affirmed: Kimberly-Clark Surpasses Q1 Expectations with Strong Sales and Strategic InitiativesBuy Rating Affirmed: Kimberly-Clark Surpasses Q1 Expectations with Strong Sales and Strategic Initiatives
markets.businessinsider.com - April 23 at 4:56 PM
Kimberly-Clark’s stock jumps 5.7% as company sweeps past earnings estimatesKimberly-Clark’s stock jumps 5.7% as company sweeps past earnings estimates
msn.com - April 23 at 4:56 PM
Kimberly-Clark rallies on higher sales and profit guidanceKimberly-Clark rallies on higher sales and profit guidance
msn.com - April 23 at 4:56 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Abbott Laboratories logo

Abbott Laboratories

NYSE:ABT
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
Dover logo

Dover

NYSE:DOV
Dover Corporation provides equipment and components, consumable supplies, aftermarket parts, software and digital solutions, and support services worldwide. The company's Engineered Products segment provides various equipment, component, software, solution, and services that are used in vehicle aftermarket, waste handling, industrial automation, aerospace and defense, industrial winch and hoist, and fluid dispensing end-market. This segment offers manual and power clamp, rotary and linear mechanical indexer, conveyor, pick and place unit, glove port, and manipulator, as well as end-of-arm robotic gripper, slide, and end effector; winches, hoists, bearings, drives, and electric monitoring system; and radio frequency and microwave filters and switches, and signal intelligence solutions. Its Clean Energy & Fueling segment offers component, equipment, and software and service solution enabling safe storage and transport of fuel, cryogenic gases, and hazardous fluids, as well as operation of retail fueling and vehicle wash establishment. The company's Imaging & Identification segment provides precision marking and coding, product traceability equipment, brand protection, and digital textile printing equipment and solution, as well as related consumable, software, and service to packaged and consumer goods, pharmaceutical, manufacturing, fashion and apparel, and other end-market. Its Pumps & Process Solutions segment manufactures specialty pump, connector, flow meter, fluid connecting solution, plastics and polymer processing equipment, and engineered components for rotating and reciprocating machines. The company's Climate & Sustainability Technologies segment manufactures refrigeration system, refrigeration display case, commercial glass refrigerator and freezer door, and brazed plate heat exchanger for industrial heating and cooling, and residential climate control applications. The company was incorporated in 1947 and is headquartered in Downers Grove, Illinois.
Kimberly-Clark logo

Kimberly-Clark

NYSE:KMB
Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products in the United States. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The company's Personal Care segment offers disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Thinx, Poise, Depend, Plenitud, Softex, and other brand names. Its Consumer Tissue segment provides facial and bathroom tissues, paper towels, napkins, and related products under the Kleenex, Scott, Cottonelle, Viva, Andrex, Scottex, Neve, and other brand names. The company's K-C Professional segment offers wipers, tissues, towels, apparel, personal protective equipment, soaps, and sanitizers under the Kleenex, Scott, WypAll, Kimtech, and KleenGuard brands. It also sells household use products directly to supermarkets, mass merchandisers, drugstores, warehouse clubs, variety and department stores, and other retail outlets, as well as through other distributors and e-commerce; and away-from-home use products directly to distributors, manufacturing, lodging, office building, food service, and public facilities, as well as through e-commerce. Kimberly-Clark Corporation was founded in 1872 and is headquartered in Dallas, Texas.